Adenomesenteritis following SARS-CoV-2 Vaccination in Children: A Case Report and Review of The Literature

At present, the vaccine authorized in children aged 5 years and older is the BNT162b2 messenger RNA COVID-19 vaccine. Unlike adults, there is limited data available in the pediatric age describing adverse events after vaccine. We report a case of adenomesenteritis in a young girl following the first...

Descripción completa

Detalles Bibliográficos
Autores principales: Bloise, Silvia, Marcellino, Alessia, Martucci, Vanessa, Sanseviero, Mariateresa, Testa, Alessia, Del Giudice, Emanuela, Spatuzzo, Mattia, Sermoneta, Daniel, Ventriglia, Flavia, Lubrano, Riccardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321070/
https://www.ncbi.nlm.nih.gov/pubmed/35883977
http://dx.doi.org/10.3390/children9070993
_version_ 1784755948122800128
author Bloise, Silvia
Marcellino, Alessia
Martucci, Vanessa
Sanseviero, Mariateresa
Testa, Alessia
Del Giudice, Emanuela
Spatuzzo, Mattia
Sermoneta, Daniel
Ventriglia, Flavia
Lubrano, Riccardo
author_facet Bloise, Silvia
Marcellino, Alessia
Martucci, Vanessa
Sanseviero, Mariateresa
Testa, Alessia
Del Giudice, Emanuela
Spatuzzo, Mattia
Sermoneta, Daniel
Ventriglia, Flavia
Lubrano, Riccardo
author_sort Bloise, Silvia
collection PubMed
description At present, the vaccine authorized in children aged 5 years and older is the BNT162b2 messenger RNA COVID-19 vaccine. Unlike adults, there is limited data available in the pediatric age describing adverse events after vaccine. We report a case of adenomesenteritis in a young girl following the first dose of vaccine.
format Online
Article
Text
id pubmed-9321070
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93210702022-07-27 Adenomesenteritis following SARS-CoV-2 Vaccination in Children: A Case Report and Review of The Literature Bloise, Silvia Marcellino, Alessia Martucci, Vanessa Sanseviero, Mariateresa Testa, Alessia Del Giudice, Emanuela Spatuzzo, Mattia Sermoneta, Daniel Ventriglia, Flavia Lubrano, Riccardo Children (Basel) Case Report At present, the vaccine authorized in children aged 5 years and older is the BNT162b2 messenger RNA COVID-19 vaccine. Unlike adults, there is limited data available in the pediatric age describing adverse events after vaccine. We report a case of adenomesenteritis in a young girl following the first dose of vaccine. MDPI 2022-07-01 /pmc/articles/PMC9321070/ /pubmed/35883977 http://dx.doi.org/10.3390/children9070993 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Bloise, Silvia
Marcellino, Alessia
Martucci, Vanessa
Sanseviero, Mariateresa
Testa, Alessia
Del Giudice, Emanuela
Spatuzzo, Mattia
Sermoneta, Daniel
Ventriglia, Flavia
Lubrano, Riccardo
Adenomesenteritis following SARS-CoV-2 Vaccination in Children: A Case Report and Review of The Literature
title Adenomesenteritis following SARS-CoV-2 Vaccination in Children: A Case Report and Review of The Literature
title_full Adenomesenteritis following SARS-CoV-2 Vaccination in Children: A Case Report and Review of The Literature
title_fullStr Adenomesenteritis following SARS-CoV-2 Vaccination in Children: A Case Report and Review of The Literature
title_full_unstemmed Adenomesenteritis following SARS-CoV-2 Vaccination in Children: A Case Report and Review of The Literature
title_short Adenomesenteritis following SARS-CoV-2 Vaccination in Children: A Case Report and Review of The Literature
title_sort adenomesenteritis following sars-cov-2 vaccination in children: a case report and review of the literature
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321070/
https://www.ncbi.nlm.nih.gov/pubmed/35883977
http://dx.doi.org/10.3390/children9070993
work_keys_str_mv AT bloisesilvia adenomesenteritisfollowingsarscov2vaccinationinchildrenacasereportandreviewoftheliterature
AT marcellinoalessia adenomesenteritisfollowingsarscov2vaccinationinchildrenacasereportandreviewoftheliterature
AT martuccivanessa adenomesenteritisfollowingsarscov2vaccinationinchildrenacasereportandreviewoftheliterature
AT sansevieromariateresa adenomesenteritisfollowingsarscov2vaccinationinchildrenacasereportandreviewoftheliterature
AT testaalessia adenomesenteritisfollowingsarscov2vaccinationinchildrenacasereportandreviewoftheliterature
AT delgiudiceemanuela adenomesenteritisfollowingsarscov2vaccinationinchildrenacasereportandreviewoftheliterature
AT spatuzzomattia adenomesenteritisfollowingsarscov2vaccinationinchildrenacasereportandreviewoftheliterature
AT sermonetadaniel adenomesenteritisfollowingsarscov2vaccinationinchildrenacasereportandreviewoftheliterature
AT ventrigliaflavia adenomesenteritisfollowingsarscov2vaccinationinchildrenacasereportandreviewoftheliterature
AT lubranoriccardo adenomesenteritisfollowingsarscov2vaccinationinchildrenacasereportandreviewoftheliterature

Ejemplares similares